Direct oral anticoagulants (DOAC) for prevention of recurrent arterial or venous thromboembolic events (ATE/VTE) in myeloproliferative neoplasms - Concepedia

Concepedia

Publication | Open Access

Direct oral anticoagulants (DOAC) for prevention of recurrent arterial or venous thromboembolic events (ATE/VTE) in myeloproliferative neoplasms

DOI Full Paper Access

26

Citations

27

References

2020

Year

Karlo Huenerbein, Parvis Sadjadian, Tatjana Becker, Vera Kolatzki, Eva Deventer, Carina Engelhardt, Martin Grießhammer, Kai Wille

Annals of Hematology

References

	Year	Citations

Page 1